I am a
Home I AM A Search Login

Papers of the Week

2020 Apr 24


Soluble Klotho: a possible predictor of quality of life in acromegaly patients.


Coopmans EC, El-Sayed N, Frystyk J, Magnusson NE, Jørgensen J O, van der Lely A-J, Janssen JAMJL, Muhammad A, Neggers SJCMM
Endocrine. 2020 Apr 24.
PMID: 32333268.


Although quality of life (QoL) is improved in patients with acromegaly after disease control, QoL correlates only weakly with traditional biomarkers. Our objective is to investigate a potential relation between the new serum biomarker soluble Klotho (sKlotho), GH and insulin-like growth factor 1 (IGF-1) levels, and QoL.